Abstract
The features of the chemistry of 4-thiazolidinone and isatin as privileged scaffolds were described in a number of reviews in which the main approaches to the synthesis of mentioned heterocycles and their pharmacological action were analyzed. However, the 4-thiazolidinone-indoline conjugates as well as isatin based heterocyclic hybrids as biologically active compounds is poorly discussed in the context of pharmacophore hybrid approach. Therefore, the purpose of this review is to summarize the data about the synthesis and biological activity of heterocyclic systems with thiazolidinone and 2-oxoindoline fragments in molecules and other heteryl-substituted indolines as promising objects of modern organic and medicinal chemistry.
Keywords: Biological activity, indolines, synthesis, 4-thiazolidinones.
Graphical Abstract
Mini-Reviews in Organic Chemistry
Title:Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Volume: 12 Issue: 1
Author(s): Dmytro Havrylyuk, Borys Zimenkovsky and Roman Lesyk
Affiliation:
Keywords: Biological activity, indolines, synthesis, 4-thiazolidinones.
Abstract: The features of the chemistry of 4-thiazolidinone and isatin as privileged scaffolds were described in a number of reviews in which the main approaches to the synthesis of mentioned heterocycles and their pharmacological action were analyzed. However, the 4-thiazolidinone-indoline conjugates as well as isatin based heterocyclic hybrids as biologically active compounds is poorly discussed in the context of pharmacophore hybrid approach. Therefore, the purpose of this review is to summarize the data about the synthesis and biological activity of heterocyclic systems with thiazolidinone and 2-oxoindoline fragments in molecules and other heteryl-substituted indolines as promising objects of modern organic and medicinal chemistry.
Export Options
About this article
Cite this article as:
Havrylyuk Dmytro, Zimenkovsky Borys and Lesyk Roman, Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids, Mini-Reviews in Organic Chemistry 2015; 12 (1) . https://dx.doi.org/10.2174/1570193X11666141028231910
DOI https://dx.doi.org/10.2174/1570193X11666141028231910 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) ADAM-Integrin Interactions: Potential Integrin Regulated Ectodomain Shedding Activity
Current Pharmaceutical Design Antisense Strategies in Therapy of Gliomas
Current Signal Transduction Therapy Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances
Current Molecular Pharmacology Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease
Current Topics in Medicinal Chemistry The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Current Molecular Medicine Cancer Preventive Phytochemicals as Speed Breakers in Inflammatory Signaling Involved in Aberrant COX-2 Expression
Current Cancer Drug Targets Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Current Pharmaceutical Design Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Anti-Cancer Agents in Medicinal Chemistry Nanoparticle-Delivered Quercetin for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Tyrosine Kinase Inhibitors: Potential Role in Pediatric Malignant Solid Tumors
Current Cancer Drug Targets KCa3.1 Channels and Glioblastoma: In Vitro Studies
Current Neuropharmacology Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Stem Cell Regenerative Potential Combined with Nanotechnology and Tissue Engineering for Myocardial Regeneration
Current Stem Cell Research & Therapy Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
Current Stem Cell Research & Therapy Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology